Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2024-01-19 M&A Activity
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Posting of Offer Document and Circular
M&A Activity Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 3411A') dated 19 January 2024. The content explicitly details an 'all share offer for TMT Acquisition plc by Belluscura plc', an 'Increased Offer', the 'Posting of Offer Document', and references the 'Takeover Code' and 'Panel'. This clearly identifies the document as a formal announcement related to a merger or takeover activity. This aligns perfectly with the definition for M&A Activity (TAR). Although it is an RNS, the specific subject matter (Takeover Offer) makes TAR the most precise classification over the general RNS fallback.
2024-01-19 English
Extension to deadline for posting Offer Document
Report Publication Announcement Classification · 99% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content discusses an update regarding a recommended all-share offer (takeover bid) between Belluscura PLC and TMT Acquisition plc, specifically announcing a delay in posting the Offer Document. This subject matter directly relates to merger proposals or takeover bids, which corresponds to the M&A Activity category (TAR). Although it is an update announcement, the core subject is the transaction itself, making TAR more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2023-12-22 English
Chinese registration and Trading Update
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is explicitly stated to be information published via a 'Regulatory Information Service' (RNS). It contains a trading update, news about regulatory approval (NMPA in China), and general business updates. The structure, inclusion of contact details for PR/Nominated Adviser/Broker, and the concluding boilerplate text referencing RNS and the London Stock Exchange strongly indicate this is a regulatory news announcement. Since it is not a full Annual Report (10-K), a specific financial release (ER/IR), or a proxy statement, and it functions as a general regulatory disclosure, the most appropriate classification is Regulatory Filings (RNS). The document length (8387 chars) is substantial, but the content is an announcement of events and updates, not the detailed financial report itself.
2023-12-20 English
Belluscura Receives Approval in Singapore
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated '12 December 2023'. It announces specific corporate news: 'Belluscura Receives Approval to Distribute the X-PLOR Portable Oxygen Concentrator in Singapore'. The text concludes with contact information and a section explicitly stating, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This structure strongly indicates a general regulatory or news announcement distributed via the RNS system, which is not a formal financial report like a 10-K or IR. Since it is a specific corporate update that doesn't fit the other specialized categories (like DIV, DIRS, or ER), the most appropriate fallback category for a general regulatory announcement distributed via RNS is 'Regulatory Filings' (RNS). It is not an announcement of a report publication (RPA) because it contains substantive news, not just a notice that a report is available.
2023-12-12 English
Extension to deadline for posting Offer Document
M&A Activity Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 9599U') dated November 28, 2023. The core subject is an 'Recommended all share offer for TMT Acquisition plc by Belluscura plc' and specifically announces a 'Grant of extension to deadline for posting of Offer Document'. This relates directly to a takeover bid and associated regulatory compliance (mentioning the Panel on Takeovers and Mergers, Rule 8.3 of the Code, and Part 28 of the Companies Act 2006). This subject matter falls under Merger/Takeover Activity. The definition for M&A Activity (Code: TAR) covers 'Announcements and documents related to merger proposals or takeover bids.' Although it is an announcement about a delay in posting the Offer Document, the primary context is the takeover bid itself, making TAR the most specific fit over the general 'RNS' fallback. The document length is substantial (over 20k characters), suggesting it is more than just a brief publication notice (RPA).
2023-11-28 English
Replacement: Rule 2.7 Announcement
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is an amendment to a 'Rule 2.7 Announcement' concerning a 'Recommended all share offer for TMT Acquisition plc by Belluscura plc'. A Rule 2.7 announcement in the UK context is the formal offer document made under the Takeover Code, which falls under the category of M&A Activity (Takeover/Merger). The text details the offer terms (share exchange ratio), valuation, strategic rationale, and conditions related to the takeover. This strongly aligns with the definition of M&A Activity (TAR). Although it is an amendment to a previous announcement, the core subject matter is the takeover offer itself, not just the announcement of the report's publication (RPA) or a general regulatory filing (RNS).
2023-11-01 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.